|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported that there was resistance during cuff inflation and deflation after endotracheal intubation.It was also stated that ventilation was properly performed even the intubation tube felt a sense of discomfort in the cuff.Additionally, there was no defect such as holes in the cuff, and after collection, tried to performed a cuff inflation and deflation but did not feel any particular sense of discomfort.The tube was replaced with no further impact on the patient.
|
|
Additional information: d9, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted that the inflation line tubing was collapsed inside the lumen of the tube.Functionally, an inflation/deflation test was performed.Air was applied to the cuff using a syringe, and it was observed that inflation was difficult and deflation was hard.It was reported that there was resistance during cuff inflation and deflation after endotracheal intubation.It was also stated that ventilation was properly performed even the intubation tube felt a sense of discomfort in the cuff.Additionally, there was no defect such as holes in the cuff, and after collection, the user tried to perform a cuff inflation and deflation but they did not feel any particular sense of discomfort.The reported issue was confirmed.The most likely cause was determined to be manufacturing related.Internal process improvements have been initiated to mitigate this issue.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|